There was a notable trend of improved systolic function without significant changes in LV end-diastolic volume (LVEDV) from baseline [ 32 , 33 , 36 , 45 , 47 , 49 ].
← all excerpts
A Review of the Therapeutic Efficacy and Safety of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Models of Subacute and Chronic Myocardial Infarction.
1
—
—